Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer.
Liotta LA, Petricoin EF 3rd, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC. Liotta LA, et al. Among authors: mills gb. Gynecol Oncol. 2003 Jan;88(1 Pt 2):S25-8; discussion S37-42. doi: 10.1006/gyno.2002.6679. Gynecol Oncol. 2003. PMID: 12586081 Review. No abstract available.
Early detection of ovarian cancer: promise and reality.
Bast RC Jr, Urban N, Shridhar V, Smith D, Zhang Z, Skates S, Lu K, Liu J, Fishman D, Mills G. Bast RC Jr, et al. Cancer Treat Res. 2002;107:61-97. doi: 10.1007/978-1-4757-3587-1_3. Cancer Treat Res. 2002. PMID: 11775462 Review. No abstract available.
Use of proteomic patterns in serum to identify ovarian cancer.
Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA. Petricoin EF, et al. Among authors: mills gb. Lancet. 2002 Feb 16;359(9306):572-7. doi: 10.1016/S0140-6736(02)07746-2. Lancet. 2002. PMID: 11867112
General keynote: molecular therapeutics and pharmocogenomics.
Bast RC Jr, Mills GB. Bast RC Jr, et al. Among authors: mills gb. Gynecol Oncol. 2003 Jan;88(1 Pt 2):S84-7; discussion S93-6. doi: 10.1006/gyno.2002.6691. Gynecol Oncol. 2003. PMID: 12586093 Review. No abstract available.
Specific keynote: molecular therapeutics in ovarian cancer.
Mills GB, Fang X, Lu Y, Hasegawa Y, Eder A, Tanyi J, Tabassam FH, Mao M, Wang H, Cheng KW, Nakayama Y, Kuo W, Erickson J, Gershenson D, Kohn EC, Jaffe R, Bast RC Jr, Gray J. Mills GB, et al. Gynecol Oncol. 2003 Jan;88(1 Pt 2):S88-92; discussion S93-6. doi: 10.1006/gyno.2002.6692. Gynecol Oncol. 2003. PMID: 12586094 Review. No abstract available.
Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
Shvartsman HS, Lu KH, Lee J, Lillie J, Deavers MT, Clifford S, Wolf JK, Mills GB, Bast RC Jr, Gershenson DM, Schmandt R. Shvartsman HS, et al. Among authors: mills gb. Gynecol Oncol. 2003 Jul;90(1):44-50. doi: 10.1016/s0090-8258(03)00257-9. Gynecol Oncol. 2003. PMID: 12821340
1,145 results